Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henning Mølgaard

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Circulation. Cardiovascular Genetics|April 8, 2014
Truncating plakophilin-2 mutations in arrhythmogenic cardiomyopathy are associated with protein haploinsufficiency in both myocardium and epidermisTorsten B Rasmussen, Peter H Nissen, Johan Palmfeldt, et al.
Human Mutation|February 6, 2013
Mutated desmoglein-2 proteins are incorporated into desmosomes and exhibit dominant-negative effects in arrhythmogenic right ventricular cardiomyopathyTorsten B Rasmussen, Johan Palmfeldt, Peter H Nissen, et al.
European Journal of Heart Failure|June 27, 2018
The clinical outcome of LMNA missense mutations can be associated with the amount of mutated protein in the nuclear envelopeRasha A Al-Saaidi, Torsten B Rasmussen, Rune I D Birkler, et al.
Scandinavian Cardiovascular Journal : SCJ|October 14, 2008
Moderate mitral regurgitation in patients undergoing CABG--the MoMIC trialPer Wierup, Henrik Egeblad, Sten Lyager Nielsen, et al.
European Journal of Medical Genetics|March 1, 2015
A novel single nucleotide splice site mutation in FHL1 confirms an Emery-Dreifuss plus phenotype with pulmonary artery hypoplasia and facial dysmorphologyAnja E Pen, Mette Nyegaard, Mingyan Fang, et al.
Acta Anaesthesiologica Scandinavica|March 17, 2021
A systematic approach to weaning from extracorporeal membrane oxygenation in patients with refractory cardiac failureSivagowry R Mørk, Christian A Frederiksen, Roni R Nielsen, et al.
Journal of Clinical Medicine|November 6, 2019
Short-Term Therapies for Treatment of Acute and Advanced Heart Failure-Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?Piero Pollesello, Tuvia Ben Gal, Dominique Bettex, et al.
International Journal of Cardiology|June 3, 2017
Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapyGerhard Pölzl, Johann Altenberger, Loant Baholli, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Circulation. Cardiovascular Genetics|April 8, 2014
Truncating plakophilin-2 mutations in arrhythmogenic cardiomyopathy are associated with protein haploinsufficiency in both myocardium and epidermisTorsten B Rasmussen, Peter H Nissen, Johan Palmfeldt, et al.
Human Mutation|February 6, 2013
Mutated desmoglein-2 proteins are incorporated into desmosomes and exhibit dominant-negative effects in arrhythmogenic right ventricular cardiomyopathyTorsten B Rasmussen, Johan Palmfeldt, Peter H Nissen, et al.
European Journal of Heart Failure|June 27, 2018
The clinical outcome of LMNA missense mutations can be associated with the amount of mutated protein in the nuclear envelopeRasha A Al-Saaidi, Torsten B Rasmussen, Rune I D Birkler, et al.
Scandinavian Cardiovascular Journal : SCJ|October 14, 2008
Moderate mitral regurgitation in patients undergoing CABG--the MoMIC trialPer Wierup, Henrik Egeblad, Sten Lyager Nielsen, et al.
European Journal of Medical Genetics|March 1, 2015
A novel single nucleotide splice site mutation in FHL1 confirms an Emery-Dreifuss plus phenotype with pulmonary artery hypoplasia and facial dysmorphologyAnja E Pen, Mette Nyegaard, Mingyan Fang, et al.
Acta Anaesthesiologica Scandinavica|March 17, 2021
A systematic approach to weaning from extracorporeal membrane oxygenation in patients with refractory cardiac failureSivagowry R Mørk, Christian A Frederiksen, Roni R Nielsen, et al.
Journal of Clinical Medicine|November 6, 2019
Short-Term Therapies for Treatment of Acute and Advanced Heart Failure-Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?Piero Pollesello, Tuvia Ben Gal, Dominique Bettex, et al.
International Journal of Cardiology|June 3, 2017
Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapyGerhard Pölzl, Johann Altenberger, Loant Baholli, et al.
Pageof 5